Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hemogenyx Pharmaceuticals (HEMO) Share Price

Price 614.00p on 11-12-2025 at 09:05:01
Change 43.00p 7.53%
Buy 614.00p
Sell 570.00p
Last Trade: Buy 582.00 at 614.00p
Day's Volume: 5,675
Last Close: 571.00p
Open: 620.00p
ISIN: GB00BQVXM815
Day's Range 614.00p - 620.00p
52wk Range: 124.50p - 1,790.00p
Market Capitalisation: £36.34m
VWAP: 610.21515p
Shares in Issue: 5.92m

Hemogenyx Pharmaceuticals (HEMO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 582 614.00p Automatic Execution
08:59:17 - 11-Dec-25
Buy* 810 614.00p Ordinary
08:59:09 - 11-Dec-25
Unknown* 1 614.00p OTC Trade
08:57:39 - 11-Dec-25
Buy* 1 614.00p Automatic Execution
08:57:39 - 11-Dec-25
Buy* 1,630 610.00p Ordinary
08:53:19 - 11-Dec-25
Sell* 425 581.00p Ordinary
08:48:13 - 11-Dec-25
Sell* 17 570.00p SI Trade
08:16:23 - 11-Dec-25
Buy* 87 610.00p Ordinary
08:15:32 - 11-Dec-25
Buy* 100 610.00p Ordinary
08:13:43 - 11-Dec-25
Buy* 2,000 614.652p Ordinary
08:10:51 - 11-Dec-25
See more Hemogenyx Pharmaceuticals trades

Hemogenyx Pharmaceuticals (HEMO) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Dec 2025 (Thu) 620.00 620.00 614.00 571.00 5,675
10th Dec 2025 (Wed) 548.00 628.00 548.00 571.00 32,979
9th Dec 2025 (Tue) 600.00 738.00 546.00 559.00 130,434
8th Dec 2025 (Mon) 477.00 632.00 470.00 600.00 99,894
5th Dec 2025 (Fri) 414.00 510.00 390.00 464.00 251,091
4th Dec 2025 (Thu) 520.00 520.00 403.00 412.50 127,480
3rd Dec 2025 (Wed) 570.00 574.00 512.00 522.00 63,731
2nd Dec 2025 (Tue) 618.00 620.00 618.00 600.00 30,248
1st Dec 2025 (Mon) 590.00 640.00 590.00 614.00 1,922
28th Nov 2025 (Fri) 680.00 680.00 594.00 594.00 67,509
27th Nov 2025 (Thu) 606.00 700.00 600.00 696.00 40,984
26th Nov 2025 (Wed) 598.00 642.00 552.00 620.00 62,147
25th Nov 2025 (Tue) 680.00 680.00 548.00 575.00 210,650
24th Nov 2025 (Mon) 784.00 784.00 660.00 680.00 81,930
21st Nov 2025 (Fri) 860.00 860.00 760.00 790.00 16,482
20th Nov 2025 (Thu) 904.00 904.00 690.00 852.00 77,248
19th Nov 2025 (Wed) 830.00 900.00 830.00 880.00 13,519
18th Nov 2025 (Tue) 854.00 900.00 852.00 900.00 30,300
17th Nov 2025 (Mon) 860.00 940.00 860.00 884.00 25,548
14th Nov 2025 (Fri) 950.00 950.00 874.00 874.00 22,729
13th Nov 2025 (Thu) 920.00 922.00 892.00 902.00 17,302
12th Nov 2025 (Wed) 960.00 960.00 856.00 856.00 11,929
11th Nov 2025 (Tue) 926.00 962.00 870.00 870.00 10,382
See more Hemogenyx Pharmaceuticals price history

Hemogenyx Pharmaceuticals (HEMO) Regulatory News

Date Source Headline
8th Dec 2025 12:48 pm RNS Holding(s) in Company
28th Nov 2025 7:00 am RNS Total Voting Rights
19th Nov 2025 11:47 am RNS Publication of Prospectus
29th Oct 2025 7:00 am RNS Clinical Trial Update and Grant of Share Awards
6th Oct 2025 7:00 am RNS Clearance to Initiate Pediatric Enrolment
30th Sep 2025 7:00 am RNS Half-year Report
30th Sep 2025 7:00 am RNS Total Voting Rights
23rd Sep 2025 7:00 am RNS Hemogenyx Signs Letter of Intent
18th Sep 2025 1:16 pm RNS Holding(s) in Company
17th Sep 2025 7:00 am RNS Third Patient Safety
See more Hemogenyx Pharmaceuticals regulatory news

Hemogenyx Pharmaceuticals (HEMO) Share News

Hemogenyx secures clearance for pediatric enrolment in leukemia trial

6th Oct 2025 14:22

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Hemogenyx says exploring commercialisation of treatment for leukaemia

23rd Sep 2025 15:51

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it is has signed a letter of intent with Cellin Technologies OU, a Tallinn-based cell therapy company. Read More

Hemogenyx shares jump as third patient treated for leukaemia form

17th Sep 2025 11:54

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia. Read More

Hemogenyx inks manufacturing partnership deal with Made Scientific

8th Sep 2025 16:27

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has agreed a manufacturing partnership with US-based cell therapy contract development and manufacturing organisation Made Scientific. Read More

See more Hemogenyx Pharmaceuticals news
FTSE 100 Latest
Value9,661.18
Change5.65

Login to your account

Forgot Password?

Not Registered